Status:
RECRUITING
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Lead Sponsor:
BioMarin Pharmaceutical
Conditions:
Hypochondroplasia
Eligibility:
All Genders
Up to 15 years
Brief Summary
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Eligibility Criteria
Inclusion
- Participants must be ≤ 15 years old at the time of signing the informed consent
- Participants must have genetic confirmation of Hypochondroplasia diagnosis
Exclusion
- Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
- Received an investigational product or medical device within 6 months before the Screening visit
Key Trial Info
Start Date :
November 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2043
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06212947
Start Date
November 27 2023
End Date
December 31 2043
Last Update
April 3 2025
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix Children's Hospital
Phoenix, Arizona, United States, 85016
2
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
3
UCSF Benioff Children's Hospital
Oakland, California, United States, 94609
4
Nemours Alfred I. Dupont Hospital for Children
Wilmington, Delaware, United States, 19803